| Current Concept: |
| |
Fullyspecifiedname:
|
Myasthenia gravis (disorder) |
| |
ConceptId:
|
91637004 |
SNOMED Definition:
(Full definition may include Is A relationships NOT present in Subset) |
| |
Is a |
|
Antibody-mediated activation and inactivation (disorder) |
| |
Is a |
|
Autoimmune disease (disorder) |
| |
Is a |
|
Combined disorder of muscle AND peripheral nerve (disorder) |
| |
Is a |
|
Disorder of neuromuscular transmission (disorder) |
| |
Is a |
|
Immune-mediated neuropathy (disorder) |
| Group 1 |
| |
Finding site (attribute) |
|
Neuromuscular junction (cell structure)
|
| |
Pathological process (attribute) |
|
Autoimmune process (qualifier value)
|
| Group 2 |
| |
Finding site (attribute) |
|
Skeletal muscle structure (body structure)
|
| Group 3 |
| |
Pathological process (attribute) |
|
Hypersensitivity process (qualifier value)
|
| |
This concept is sufficiently defined.
|
| Default Descriptions (Synonyms):
Show DescriptionIDs
|
| |
Fully specified name: |
Myasthenia gravis (disorder) |
| |
Synonym: |
Erb-Goldflam disease |
| |
Synonym: |
MG - Myasthenia gravis |
| |
Synonym: |
Miastenia grave |
| |
Synonym: |
Myasthenia gravis |
|
AAEP Diagnosis Terms
Description Preferences: |
| |
Preferred:
|
Myasthenia gravis |
